Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

HIV Diagnosis and Treatment through Advanced Technologies.

Zulfiqar HF, Javed A, Sumbal, Afroze B, Ali Q, Akbar K, Nadeem T, Rana MA, Nazar ZA, Nasir IA, Husnain T.

Front Public Health. 2017 Mar 7;5:32. doi: 10.3389/fpubh.2017.00032. eCollection 2017. Review.

2.

IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages.

Wang X, Wang H, Liu MQ, Li JL, Zhou RH, Zhou Y, Wang YZ, Zhou W, Ho WZ.

Front Immunol. 2017 Mar 6;8:210. doi: 10.3389/fimmu.2017.00210. eCollection 2017.

3.

Interferon Lambda: Modulating Immunity in Infectious Diseases.

Syedbasha M, Egli A.

Front Immunol. 2017 Feb 28;8:119. doi: 10.3389/fimmu.2017.00119. eCollection 2017. Review.

4.

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.

Bruening J, Weigel B, Gerold G.

J Immunol Res. 2017;2017:7232361. doi: 10.1155/2017/7232361. Epub 2017 Feb 1. Review.

5.

Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway.

Liu MQ, Zhao M, Kong WH, Tang L, Wang F, Zhu ZR, Wang X, Qiu HY, Zhou DJ, Wang X, Ho WZ, Zhou W.

Oncotarget. 2017 Apr 4;8(14):22524-22533. doi: 10.18632/oncotarget.15121.

6.

Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.

Alves CF, Grott CS, Lunge VR, Béria JU, Tietzmann DC, Stein AT, Simon D.

Genet Mol Biol. 2016 Jul-Sep;39(3):374-9. doi: 10.1590/1678-4685-GMB-2015-0106. Epub 2016 Jul 25.

7.

Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples.

Cervantes CA, Oliveira LM, Manfrere KC, Lima JF, Pereira NZ, Duarte AJ, Sato MN.

Sci Rep. 2016 May 11;6:25875. doi: 10.1038/srep25875.

8.

Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection.

Moqueet N, Cooper C, Gill J, Hull M, Platt RW, Klein MB; Canadian Co-infection Cohort.

J Infect Dis. 2016 Jul 1;214(1):80-6. doi: 10.1093/infdis/jiw088. Epub 2016 Mar 16.

9.

Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.

Zhou L, Li JL, Zhou Y, Liu JB, Zhuang K, Gao JF, Liu S, Sang M, Wu JG, Ho WZ.

Mol Hum Reprod. 2015 Dec;21(12):917-29. doi: 10.1093/molehr/gav058. Epub 2015 Oct 26.

10.

Interferon lambda inhibits dengue virus replication in epithelial cells.

Palma-Ocampo HK, Flores-Alonso JC, Vallejo-Ruiz V, Reyes-Leyva J, Flores-Mendoza L, Herrera-Camacho I, Rosas-Murrieta NH, Santos-López G.

Virol J. 2015 Sep 28;12:150. doi: 10.1186/s12985-015-0383-4.

11.

Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages.

Dai M, Wang X, Li JL, Zhou Y, Sang M, Liu JB, Wu JG, Ho WZ.

FASEB J. 2015 Dec;29(12):4978-88. doi: 10.1096/fj.15-273128. Epub 2015 Aug 21.

12.

The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.

Egli A, Santer DM, O'Shea D, Tyrrell DL, Houghton M.

Emerg Microbes Infect. 2014 Jul;3(7):e51. doi: 10.1038/emi.2014.51. Epub 2014 Jul 16. Review.

13.

IL28B is associated with outcomes of chronic HBV infection.

Shi X, Chi X, Pan Y, Gao Y, Li W, Yang C, Zhong J, Xu D, Zhang M, Minuk G, Jiang J, Niu J.

Yonsei Med J. 2015 May;56(3):625-33. doi: 10.3349/ymj.2015.56.3.625.

14.

Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques.

Sang M, Liu JB, Dai M, Wu JG, Ho WZ.

Antiviral Res. 2014 Dec;112:103-12. doi: 10.1016/j.antiviral.2014.10.008. Epub 2014 Oct 23.

15.

The role of macrophage IL-10/innate IFN interplay during virus-induced asthma.

Zdrenghea MT, Makrinioti H, Muresan A, Johnston SL, Stanciu LA.

Rev Med Virol. 2015 Jan;25(1):33-49. doi: 10.1002/rmv.1817. Epub 2014 Nov 27. Review.

16.

Impact and regulation of lambda interferon response in human metapneumovirus infection.

Baños-Lara Mdel R, Harvey L, Mendoza A, Simms D, Chouljenko VN, Wakamatsu N, Kousoulas KG, Guerrero-Plata A.

J Virol. 2015 Jan;89(1):730-42. doi: 10.1128/JVI.02897-14. Epub 2014 Oct 29.

17.

Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.

Wang Y, Li J, Wang X, Zhou Y, Zhang T, Ho W.

J Interferon Cytokine Res. 2015 Mar;35(3):213-21. doi: 10.1089/jir.2014.0064. Epub 2014 Sep 30.

18.

Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.

Nguyen PV, Kafka JK, Ferreira VH, Roth K, Kaushic C.

Cell Mol Immunol. 2014 Sep;11(5):410-27. doi: 10.1038/cmi.2014.41. Epub 2014 Jun 30. Review.

19.

Efficacy of IFN-λ1 to protect human airway epithelial cells against human rhinovirus 1B infection.

Gulraiz F, Bellinghausen C, Dentener MA, Reynaert NL, Gaajetaan GR, Beuken EV, Rohde GG, Bruggeman CA, Stassen FR.

PLoS One. 2014 Apr 21;9(4):e95134. doi: 10.1371/journal.pone.0095134. eCollection 2014.

20.

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.

Real LM, Neukam K, Herrero R, Guardiola JM, Reiberger T, Rivero-Juarez A, Salazar J, Mandorfer M, Merino D, Soriano V, Rivero A, Macías J, Pineda JA, Caruz A.

PLoS One. 2014 Apr 18;9(4):e95515. doi: 10.1371/journal.pone.0095515. eCollection 2014.

Supplemental Content

Support Center